Serum HPV vaccine Cervavac hits mkt; 2-3 mn doses this yr

Homegrown pharma major Serum Institute of India has launched its indigenous Human Papillomavirus (HPV) vaccine, Cervavac, across India.

- Priyanka Sharma

The company will be producing 2-3 million doses this year, a person in the know said, seeking anonymity. While the government’s procurement is underway, it may take some time, a person familiar with the matter said.

"It has already delivered the vaccine to corporate hospitals, private clinics and medical practitioners in Delhi, West Bengal, Maharashtra, Telangana, Rajasthan, Uttar Pradesh, Bihar and Odisha."